Lumiere Therapeutics
Latest round
- Angel
Last raised
- Jun 2022
Total raised
- $15M
Investors
- 3
About Lumiere Therapeutics
, trading as Lumiere Therapeutics, is a healthcare company that focuses on developing human genetic diagnostic and therapeutic technologies. The company's founder and chief scientist officer (CSO), Professor Yangzhou Song, was the dean of the Chinese Academy of Life Sciences. The company's main business is human gene diagnosis and therapy technology development, medical research and experimental development, cell technology research and application, engineering and technology research and experimental development, experimental analysis instruments sales, instrumentation sales and chemical products sales. The company generates revenue by developing human genetic diagnostic and therapeutic technologies.
Who invested in Lumiere Therapeutics
3 investors across 1 round
See all investors in Lumiere Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Angel
Jun 13, 2022
Amount
$15M
Investors
Questions about Lumiere Therapeutics
Who invested in Lumiere Therapeutics?
Lumiere Therapeutics has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Lumiere Therapeutics raised?
Lumiere Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Lumiere Therapeutics last raise money?
Lumiere Therapeutics's most recent round on record is a Angel, in Jun 2022.
What does Lumiere Therapeutics do?
, trading as Lumiere Therapeutics, is a healthcare company that focuses on developing human genetic diagnostic and therapeutic technologies.
Where is Lumiere Therapeutics headquartered?
Lumiere Therapeutics is headquartered in Suzhou, China.
Which VCs invest in companies like Lumiere Therapeutics?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at Lumiere Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Angel
Raising like Lumiere Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.